ESR1 and prostate cancer: Collectively, these observations provide evidence for the hypothesis that AR can be an oncogene in certain ERα-negative breast cancers by acting as a “surrogate” ERα or by recapitulating the oncogenic program that stimulates growth of prostate cancer cells [4].